Wolverine Trading’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$82.7K Sell
21,820
-23,708
-52% -$91.5K ﹤0.01% 5264
2025
Q2
$159K Buy
+45,528
New +$246K ﹤0.01% 4020
2025
Q1
Sell
-15,543
Closed -$98.5K 4679
2024
Q4
$114K Sell
15,543
-12,728
-45% -$97.2K ﹤0.01% 4761
2024
Q3
$183K Buy
28,271
+837
+3% +$5.67K ﹤0.01% 4148
2024
Q2
$182K Sell
27,434
-4,495
-14% -$33.2K ﹤0.01% 3880
2024
Q1
$325K Sell
31,929
-31,428
-50% -$320K ﹤0.01% 3269
2023
Q4
$713K Buy
+63,357
New +$265K ﹤0.01% 2597
2023
Q3
Sell
-10,553
Closed -$30.3K 4434
2023
Q2
$36.9K Buy
+10,553
New +$47.4K ﹤0.01% 4012
2022
Q4
Sell
-38,227
Closed -$429K 3896
2022
Q3
$482K Buy
38,227
+14,085
+58% +$208K ﹤0.01% 2633
2022
Q2
$284K Buy
+24,142
New +$149K ﹤0.01% 3127
2022
Q1
Sell
-33,555
Closed -$300K 5335
2021
Q4
$300K Buy
33,555
+16,825
+101% +$179K ﹤0.01% 4154
2021
Q3
$213K Buy
16,730
+5,157
+45% +$62.7K ﹤0.01% 5239
2021
Q2
$184K Sell
11,573
-653
-5% -$8.93K ﹤0.01% 5069
2021
Q1
$166K Sell
12,226
-13,480
-52% -$218K ﹤0.01% 5178
2020
Q4
$290K Buy
+25,706
New +$303K ﹤0.01% 3786

Other funds holding ALT

Wolverine Trading's ALT Position: Q3 2025 in Review

Wolverine Trading reduced its Altimmune (ALT) stake by 52% in Q3 2025, selling an estimated $91.5K and leaving 21,820 shares worth $82.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5264.

Wolverine Trading first reported a position in ALT in Q4 2020 and has held it in 15 quarters since. The position peaked at $713K in Q4 2023. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Wolverine Trading held 21,820 shares of Altimmune worth $82.7K as of Q3 2025.
  • Wolverine Trading sold 23,708 Altimmune shares in Q3 2025, an estimated $91.5K.
  • Altimmune made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5264 holding.
  • Wolverine Trading first reported a position in Altimmune in Q4 2020 and has held it in 15 quarters since.
  • Wolverine Trading's Altimmune position peaked at $713K in Q4 2023.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.